Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atara Biotherapeutics, Inc. | 271,943 | reported | 15 Feb 2019 | tx 92+523,165−294,119 |
| Elicio Therapeutics, Inc. | 57,381 | reported | 02 Feb 2026 | tx 5+176,700 |
| Surrozen, Inc./DE | 0 | reported | 11 Aug 2021 | tx 2+30,000−30,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | Elicio Therapeutics, Inc. | 25,400 | 0.00 USD | |
| 02 Feb 2026 | GRANT_AWARD | Elicio Therapeutics, Inc. | 50,900 | 0.00 USD | deriv |
| 03 Feb 2025 | GRANT_AWARD | Elicio Therapeutics, Inc. | 44,000 | 0.00 USD | deriv |
| 30 Sept 2024 | GRANT_AWARD | Elicio Therapeutics, Inc. | 28,200 | 0.00 USD | deriv |
| 01 Feb 2024 | GRANT_AWARD | Elicio Therapeutics, Inc. | 28,200 | 0.00 USD | deriv |
| 11 Aug 2021 | GRANT_AWARD | Surrozen, Inc./DE | 30,000 | — | |
| 11 Aug 2021 | OTHER | Surrozen, Inc./DE | 30,000 | 0.00 USD | deriv |
| 15 Feb 2019 | SALE | Atara Biotherapeutics, Inc. | 775 | 39.59 USD | |
| 11 Feb 2019 | SALE | Atara Biotherapeutics, Inc. | 13,975 | 38.55 USD | |
| 06 Feb 2019 | TAX_WITHHOLDING | Atara Biotherapeutics, Inc. | 1,512 | 38.47 USD | |
| 06 Feb 2019 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 15,000 | 0.00 USD | |
| 06 Feb 2019 | SALE | Atara Biotherapeutics, Inc. | 2,677 | 38.04 USD | |
| 06 Feb 2019 | SALE | Atara Biotherapeutics, Inc. | 9,698 | 38.78 USD | |
| 06 Feb 2019 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 15 Nov 2018 | SALE | Atara Biotherapeutics, Inc. | 775 | 33.81 USD | |
| 26 Sept 2018 | SALE | Atara Biotherapeutics, Inc. | 13,500 | 43.08 USD | |
| 25 Sept 2018 | SALE | Atara Biotherapeutics, Inc. | 3,500 | 41.23 USD | |
| 24 Sept 2018 | SALE | Atara Biotherapeutics, Inc. | 3,931 | 40.53 USD | |
| 25 Sept 2018 | SALE | Atara Biotherapeutics, Inc. | 10,000 | 40.26 USD | |
| 24 Sept 2018 | SALE | Atara Biotherapeutics, Inc. | 14,069 | 39.74 USD | |
| 15 Aug 2018 | SALE | Atara Biotherapeutics, Inc. | 775 | 37.54 USD | |
| 15 May 2018 | EXERCISE | Atara Biotherapeutics, Inc. | 25,000 | 11.00 USD | |
| 15 May 2018 | SALE | Atara Biotherapeutics, Inc. | 9,252 | 46.02 USD | |
| 15 May 2018 | SALE | Atara Biotherapeutics, Inc. | 9,638 | 45.21 USD | |
| 15 May 2018 | SALE | Atara Biotherapeutics, Inc. | 6,885 | 44.44 USD |